Edward Stadtmauer

Edward Stadtmauer

UNVERIFIED PROFILE

Are you Edward Stadtmauer?   Register this Author

Register author
Edward Stadtmauer

Edward Stadtmauer

Publications by authors named "Edward Stadtmauer"

Are you Edward Stadtmauer?   Register this Author

100Publications

3166Reads

6Profile Views

Oprozomib, pomalidomide, and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma.

Clin Lymphoma Myeloma Leuk 2019 Sep 29;19(9):570-578.e1. Epub 2019 May 29.

Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.05.017DOI Listing
September 2019

Nutrition-Related Outcomes for Autologous Stem Cell Transplantation Patients.

Clin Lymphoma Myeloma Leuk 2019 Jul 6;19(7):e393-e398. Epub 2019 Apr 6.

Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.04.002DOI Listing
July 2019

Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.

Biol Blood Marrow Transplant 2019 May 24;25(5):1004-1010. Epub 2018 Nov 24.

Division of Infectious Diseases, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Healthcare Epidemiology, Infection Prevention and Control, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.11.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511289PMC
May 2019

Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract.

Bone Marrow Transplant 2019 02 24;54(2):212-217. Epub 2018 May 24.

Blood and Marrow Transplantation Program, Abramson Cancer Center and the Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41409-018-0236-z
Publisher Site
http://dx.doi.org/10.1038/s41409-018-0236-zDOI Listing
February 2019

Melphalan desensitization following immediate hypersensitivity in a patient undergoing conditioning for autologous hematopoietic cell transplantation.

J Allergy Clin Immunol Pract 2016 May-Jun;4(3):555-6. Epub 2016 Feb 13.

Division of Hematology and Oncology, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaip.2016.01.005DOI Listing
July 2018

Higher Donor Apheresis Blood Volumes Are Associated with Reduced Relapse Risk and Improved Survival in Reduced-Intensity Allogeneic Transplantations with Unrelated Donors.

Biol Blood Marrow Transplant 2018 06 2;24(6):1203-1208. Epub 2018 Feb 2.

Blood and Marrow Transplantation Program and Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.01.037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993582PMC
June 2018

Hematologic Malignancies: Plasma Cell Disorders.

Am Soc Clin Oncol Educ Book 2017 ;37:561-568

From Yale University, New Haven, CT; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_175546DOI Listing
December 2017

Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis.

Am J Hematol 2017 Sep 9;92(9):879-884. Epub 2017 Jun 9.

Hospital of the University of Pennsylvania, Department of Medicine, Division of Hematology/Oncology, Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, 19104.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24792DOI Listing
September 2017

CAR T-Cell Therapy: On the Verge of Breakthrough in Many Hematologic Malignancies.

J Adv Pract Oncol 2017 Apr 1;8(3):228-231. Epub 2017 Apr 1.

University of Pennsylvania Abramson Cancer Center, Philadelphia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003752PMC
April 2017

Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors.

Clin Genitourin Cancer 2016 12 24;14(6):524-529. Epub 2016 Mar 24.

Division of Hematology/Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.03.015DOI Listing
December 2016

Cellular and vaccine immunotherapy for multiple myeloma.

Hematology Am Soc Hematol Educ Program 2016 Dec;2016(1):521-527

Division of Hematology-Oncology and the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2016.1.521DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142464PMC
December 2016

The Promise of Chimeric Antigen Receptor Engineered T Cells in the Treatment of Hematologic Malignancies.

Cancer J 2016 Jan-Feb;22(1):27-33

From the Division of Hematology/Oncology, Department of Medicine and Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000166DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742356PMC
November 2016

Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas.

Am J Hematol 2016 07 24;91(7):672-6. Epub 2016 Apr 24.

Abramson Cancer Center and the Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24372DOI Listing
July 2016

Chimeric Antigen Receptor T Cells in Myeloma.

N Engl J Med 2016 01;374(2):194

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1512760DOI Listing
January 2016

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.

Biol Blood Marrow Transplant 2015 Dec 30;21(12):2039-2051. Epub 2015 Sep 30.

University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.09.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757494PMC
December 2015

Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.

Lancet Haematol 2015 Oct 17;2(10):e408-16. Epub 2015 Sep 17.

Division of Hematology-Oncology, Division of Internal Medicine and the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lanhae/PIIS2352-3026(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S235230261500151
Publisher Site
http://dx.doi.org/10.1016/S2352-3026(15)00151-9DOI Listing
October 2015

Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma.

Clin Lymphoma Myeloma Leuk 2015 Sep 6;15(9):536-40. Epub 2015 Jun 6.

Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.05.006DOI Listing
September 2015

Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma.

N Engl J Med 2015 Sep;373(11):1040-7

From the Division of Hematology-Oncology, Department of Medicine (A.L.G., M.V.M., D.T.V., A.D.C., B.M.W., E.A.S.), Department of Biostatistics and Epidemiology (W.-T.H.), Department of Pathology and Laboratory Medicine (S.F.L., Y.D.M., J.J.M., Z.Z., A.B., B.L.L., C.H.J.), and Abramson Cancer Center (A.L.G., M.V.M., W.-T.H., S.F.L., Y.D.M., J.J.M., Z.Z., D.T.V., A.D.C., B.M.W., K.D., N.D.S.K., A.B., B.L.L., C.H.J., E.A.S.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1504542DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646711PMC
September 2015

R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma.

Clin Lymphoma Myeloma Leuk 2015 Feb 1;15(2):92-7. Epub 2014 Aug 1.

Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2014.07.017DOI Listing
February 2015

Melphalan/total body irradiation-conditioned myeloablative allogeneic hematopoietic cell transplantation for patients with primary plasma cell leukemia.

Clin Lymphoma Myeloma Leuk 2014 Dec 2;14(6):e225-8. Epub 2014 Aug 2.

Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2014.07.012DOI Listing
December 2014

Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning.

Biol Blood Marrow Transplant 2014 Nov 10;20(11):1758-66. Epub 2014 Jul 10.

Abramson Cancer Center and the Division of Hematology & Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.07.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194246PMC
November 2014

Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells.

Clin Cancer Res 2014 Mar 11;20(5):1355-65. Epub 2014 Feb 11.

Authors' Affiliations: University of Maryland Marlene and Stewart Greenebaum Cancer Center; Center for Vaccine Development and Department of Otorhinolaryngology-Head and Neck Surgery, University of Maryland School of Medicine, Baltimore, Maryland; Oncovir Inc., Washington, District of Columbia; Department of Pathology, University of Pennsylvania; and Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2817DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557204PMC
March 2014

The evolving role of plerixafor in hematopoietic progenitor cell mobilization.

Transfusion 2013 Oct 30;53(10):2314-26. Epub 2013 Jan 30.

Department of Pathology and Cell Biology, Columbia University, New York, New York; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.12102DOI Listing
October 2013

Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era.

Am J Hematol 2013 Oct 1;88(10):890-4. Epub 2013 Aug 1.

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.23524
Publisher Site
http://dx.doi.org/10.1002/ajh.23524DOI Listing
October 2013

Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens.

Am J Hematol 2013 Aug 5;88(8):657-60. Epub 2013 Jun 5.

Division of Hematology/Oncology, Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23468DOI Listing
August 2013

Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients.

Transpl Int 2013 Jun 28;26(6):616-22. Epub 2013 Mar 28.

Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tri.12091DOI Listing
June 2013

A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma.

Br J Haematol 2012 Oct 4;159(1):58-66. Epub 2012 Aug 4.

Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2012.09251.xDOI Listing
October 2012

Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases.

J Heart Lung Transplant 2012 Mar 23;31(3):296-304. Epub 2011 Nov 23.

Abramson Cancer Center, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.healun.2011.10.013DOI Listing
March 2012

Pupil-involving third nerve palsy as a manifestation of anti-myelin-associated glycoprotein neuropathy.

J Neuroophthalmol 2011 Mar;31(1):29-33

Department of Ophthalmology, Scheie Eye Institute, Hospital of the University of Pennsylvania, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00041327-201103000-000
Publisher Site
http://dx.doi.org/10.1097/WNO.0b013e3181f2e27aDOI Listing
March 2011

The presence of amyloid in abdominal and oral mucosal tissues in patients initially diagnosed with multiple myeloma: a pilot study.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011 Mar;111(3):326-32

Department of Oral Medicine, University of Pennsylvania School of Dental Medicine, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S107921041000860
Publisher Site
http://dx.doi.org/10.1016/j.tripleo.2010.10.028DOI Listing
March 2011

What did we learn in 2010 from the phase III trials? Is maintenance therapy the new standard for myeloma?

Biol Blood Marrow Transplant 2011 Jan;17(1 Suppl):S30-2

Department of Blood and Marrow Transplantation, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791100051
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2010.11.016DOI Listing
January 2011

Tailoring initial treatment for newly diagnosed, transplantation-eligible multiple myeloma.

Oncology (Williston Park) 2010 Mar;24(3 Suppl 2):7-13

Abramson Cancer Center, University of Pennsylvania, Perelman Center for Advanced Medicine Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
March 2010